GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Univo Pharmaceuticals Ltd (XTAE:UNVO-M) » Definitions » ROE % Adjusted to Book Value

Univo Pharmaceuticals (XTAE:UNVO-M) ROE % Adjusted to Book Value : -228.57% (As of Jun. 2022)


View and export this data going back to 2011. Start your Free Trial

What is Univo Pharmaceuticals ROE % Adjusted to Book Value?

Univo Pharmaceuticals's ROE % for the quarter that ended in Jun. 2022 was -313.14%. Univo Pharmaceuticals's PB Ratio for the quarter that ended in Jun. 2022 was 1.37. Univo Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2022 was -228.57%.


Univo Pharmaceuticals ROE % Adjusted to Book Value Historical Data

The historical data trend for Univo Pharmaceuticals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Univo Pharmaceuticals ROE % Adjusted to Book Value Chart

Univo Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only - -307.13 -22.02 0.24 -11.28

Univo Pharmaceuticals Quarterly Data
Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.70 -16.01 -23.86 -36.99 -228.57

Competitive Comparison of Univo Pharmaceuticals's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Univo Pharmaceuticals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Univo Pharmaceuticals's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Univo Pharmaceuticals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Univo Pharmaceuticals's ROE % Adjusted to Book Value falls into.


;
;

Univo Pharmaceuticals ROE % Adjusted to Book Value Calculation

Univo Pharmaceuticals's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2021 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-16.36% / 1.45
=-11.28%

Univo Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-313.14% / 1.37
=-228.57%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Univo Pharmaceuticals ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Univo Pharmaceuticals's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Univo Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Harshar 20, Ashkelon, ISR, 7878329
Univo Pharmaceuticals Ltd is engaged in designing & developing drugs for the treatment of brain disorders. The company provides cannabis-based products for distribution and export to the international markets.

Univo Pharmaceuticals Headlines

No Headlines